Delivery Order SPE2DR25D3103-SPE2DR26F9J81
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Zepbound 7.5 mg/0.5 mL pen injections valued at $10,966.72. The order was awarded on November 3, 2025, on a firm fixed-price basis with an ultimate completion date of November 4, 2025, with no set-aside designation applied. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,960.14 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $7,988 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on October 20, 2025, with completion expected by October 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- The Defense Logistics Agency awarded a $36,764.00 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injections on October 28, 2025, with completion targeted for October 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement with performance at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,677.22 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,476.56 for Zepbound 15 mg/0.5 ml pen injections on November 10, 2025, with a completion date of November 12, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,107.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,863.22 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections on October 30, 2025, with completion targeted for October 31, 2025. The award utilized firm fixed pricing with no set-aside designation, reflecting competitive procurement procedures. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office division, with...
- The Defense Logistics Agency awarded a delivery order valued at $20,101.01 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's substantial Indefinite...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J81Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,476.56 for Zepbound 7.5 mg/0.5 ml pen injections on November 26, 2025, with completion scheduled for November 28, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's IDC vehicle supports military healthcare programs worldwide by supplying an extensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes medication, exemplifies the routine pharmaceutical procurement operations conducted under the broader global pharmaceutical support contract that enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/25/25 |